FDAnews
www.fdanews.com/articles/85864-lifetime-without-cold-sores-with-interceptcs

LIFETIME WITHOUT COLD SORES WITH INTERCEPTCS

April 6, 2006

The Gibson Group is pleased to announce the launch of interceptCS, an innovative device that completely revolutionizes the management of cold sores (herpes simplex -1). In contrast to other available therapies such as topical or oral antiviral medications, interceptCS doesn't 'treat' cold sores -- it prevents them before they start. CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=588123)